The anticancer drug ellipticine forms covalent DNA adducts, mediated by human cytochromes P450, through metabolism to 13-hydroxyellipticine and ellipticine N-2-oxide

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11310%2F04%3A00000707" target="_blank" >RIV/00216208:11310/04:00000707 - isvavai.cz</a>

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

The anticancer drug ellipticine forms covalent DNA adducts, mediated by human cytochromes P450, through metabolism to 13-hydroxyellipticine and ellipticine N-2-oxide

Original language description

The anticancer drug ellipticine forms covalent DNA adducts, mediated by human cytochromes P450, through metabolism to 13-hydroxyellipticine and ellipticine N-2-oxide

Czech name

Protinádorové léčivo elipticin tvoří kovalentní DNA adukty, prostřednictvím cytochromů P450, přes metabolismus na 13-hydroxyelipticin a N-2-oxid elipticinu

Czech description

Protinádorové léčivo elipticin tvoří kovalentní DNA adukty, prostřednictvím cytochromů P450, přes metabolismus na 13-hydroxyelipticin a N-2-oxid elipticinu

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

CE - Biochemistry

OECD FORD branch

—

Project

<a href="/en/project/GA203%2F01%2F0996" target="_blank" >GA203/01/0996: Study of molecular mechanism of anticancer effect of a chemotherapeutic, ellipticine</a><br>

Continuities

Z - Vyzkumny zamer (s odkazem do CEZ)

Publication year

2004

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

CANCER RESEARCH

ISSN

0008-5472

e-ISSN

—

Volume of the periodical

64

Issue of the periodical within the volume

22

Country of publishing house

US - UNITED STATES

Number of pages

7

Pages from-to

8374-8380

UT code for WoS article

—

EID of the result in the Scopus database

—